Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush.
Child, Preschool
Communicable Disease Control
Communicable Diseases
/ epidemiology
Female
Humans
Immunization Programs
/ statistics & numerical data
India
/ epidemiology
Infant
Infant, Newborn
Male
Public Health Surveillance
Quality Improvement
Vaccination
/ methods
Vaccination Coverage
/ statistics & numerical data
Vaccines
/ administration & dosage
India
Mission Indradhanush
UIP
Universal Immunization Programme
vaccine
Journal
Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
11
05
2021
received:
02
02
2021
accepted:
11
06
2021
pubmed:
16
7
2021
medline:
15
12
2021
entrez:
15
7
2021
Statut:
ppublish
Résumé
Only an estimated 62% of Indian children under the age of 2 years are fully immunized. We examined the association between India's Mission Indradhanush (MI)-a periodic intensification of the routine immunization program-which was implemented in phases across districts between March 2015 and July 2017, and routine vaccination coverage and timeliness among children. We used data from a 2015 to 2016 national survey of children (n = 29,532) and employed difference-in-difference regressions to examine binary indicators of receipt of 11 vaccines and whether vaccines were received at recommended ages. The full immunization rate was 27% higher among children under 2 years old residing in MI phase 1 and 2 districts (intervention group) as compared with those residing elsewhere (control group). The rate of receiving all vaccines at recommended ages was 8% higher in the intervention group. Receiving doses of oral polio vaccine (OPV) birth dose, OPV dose 1 (OPV1), OPV2, OPV3, bacillus Calmette-Guérin, and hepatitis B birth dose vaccines were 9%, 9%, 11%, 16%, 5%, and 19% higher in the intervention group than the control group, respectively. More research is required on the cost-effectiveness of investing in MI-type programs as compared with routine immunization.
Identifiants
pubmed: 34263929
doi: 10.1111/nyas.14657
pmc: PMC9291841
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
110-120Subventions
Organisme : Bill and Melinda Gates Foundation
ID : OPP1183738
Informations de copyright
© 2021 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of New York Academy of Sciences.
Références
BMJ. 2018 Dec 7;363:k4782
pubmed: 30530467
Hum Vaccin Immunother. 2020 Aug 2;16(8):1900-1904
pubmed: 31977283
Lancet. 2013 Jun 15;381(9883):2118-33
pubmed: 23574803
BMJ Glob Health. 2018 Jun 22;3(3):e000794
pubmed: 29946488
Lancet. 2009 May 2;373(9674):1543-9
pubmed: 19303633
Lancet Infect Dis. 2017 Dec;17(12):e420-e428
pubmed: 28757186
Science. 2019 Nov 1;366(6465):599-606
pubmed: 31672891
Cochrane Database Syst Rev. 2016 Jul 10;7:CD008145
pubmed: 27394698
Indian J Community Med. 2018 Jul-Sep;43(3):209-214
pubmed: 30294090
Indian J Med Res. 2016 Jun;143(6):801-808
pubmed: 27748306
Health Policy Plan. 2021 May 17;36(4):454-463
pubmed: 33734362
Vaccine. 2018 Jun 18;36(26):3836-3841
pubmed: 29776749
Soc Sci Med. 2020 Feb 26;250:112885
pubmed: 32143089
Lancet. 2017 Oct 28;390(10106):1972-1980
pubmed: 28939096
Indian J Med Res. 2013 May;137(5):881-94
pubmed: 23760372
Bull World Health Organ. 2016 Oct 01;94(10):728-734
pubmed: 27843162
Vaccine. 2019 Jan 21;37(4):558-564
pubmed: 30595345
J Family Med Prim Care. 2015 Oct-Dec;4(4):487-94
pubmed: 26985404
Indian Pediatr. 2014 Oct;51(10):785-800
pubmed: 25362009
Bull World Health Organ. 2014 Jul 1;92(7):533-44B
pubmed: 25110379
Vaccine. 2019 Jul 18;37(31):4336-4343
pubmed: 31227354
Indian J Med Res. 2014 Apr;139(4):491-511
pubmed: 24927336
PLoS One. 2019 Aug 16;14(8):e0218470
pubmed: 31419230
Vaccine. 2019 Apr 17;37(17):2331-2339
pubmed: 30914221
J Epidemiol Community Health. 2020 Oct;74(10):778-784
pubmed: 32586984
J Perinatol. 2016 Dec;36(s3):S9-S12
pubmed: 27924110
Vaccine. 2014 Aug 11;32 Suppl 1:A151-61
pubmed: 25091670
Ann N Y Acad Sci. 2019 Aug;1449(1):70-82
pubmed: 31180594
Indian J Public Health. 2013 Jan-Mar;57(1):8-14
pubmed: 23649136
BMJ Glob Health. 2018 May 9;3(3):e000636
pubmed: 29765775